We are live on ! Find out more
MS

Marshall & Sullivan Portfolio holdings

AUM $216M
1-Year Est. Return 12.97%
This Fund
S&P 500
This Quarter Est. Return
-12.21%
1 Year Est. Return
+12.97%
3 Year Est. Return
+82%
5 Year Est. Return
+98.09%
10 Year Est. Return
+292.06%
AUM
$115M
AUM Growth
-$22.5M
Cap. Flow
-$5.45M
Cap. Flow %
-4.74%
Top 10 Hldgs %
49.39%
Holding
48
New
2
Increased
4
Reduced
26
Closed
9

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$3.74M
2
PYPL icon
PayPal
PYPL
+$1.91M
3
MA icon
Mastercard
MA
+$1.02M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$170K
5
FTV icon
Fortive
FTV
+$56.6K

Sector Composition

Rank Sector Weight
1 Healthcare 26.11%
2 Technology 11.11%
3 Consumer Staples 9.48%
4 Consumer Discretionary 9.45%
5 Communication Services 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
1
iShares Russell 2000 ETF
IWM
$79.1B
$12.8M 11.12%
95,593
-1,026
-1% -$153K
KBE icon
2
State Street SPDR S&P Bank ETF
KBE
$1.64B
$7.59M 6.6%
203,335
-4,180
-2% -$177K
VWO icon
3
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$6.13M 5.33%
160,831
-13,621
-8% -$528K
CHD icon
4
Church & Dwight Co
CHD
$23.7B
$4.95M 4.3%
75,271
-3,234
-4% -$205K
FISV
5
Fiserv Inc
FISV
$29.7B
$4.61M 4.01%
62,739
-5,221
-8% -$404K
SYK icon
6
Stryker
SYK
$135B
$4.3M 3.73%
27,407
-982
-3% -$164K
BDX icon
7
Becton Dickinson
BDX
$46.4B
$4.2M 3.65%
19,119
-701
-4% -$163K
HD icon
8
Home Depot
HD
$337B
$4.18M 3.63%
24,319
-639
-3% -$115K
MA icon
9
Mastercard
MA
$498B
$4.11M 3.57%
21,788
+5,122
+31% +$1.02M
UNH icon
10
UnitedHealth
UNH
$382B
$3.97M 3.45%
15,920
-215
-1% -$56.8K
JNJ icon
11
Johnson & Johnson
JNJ
$640B
$3.94M 3.42%
30,505
-776
-2% -$108K
DHR icon
12
Danaher
DHR
$138B
$3.82M 3.32%
41,827
-599
-1% -$54.4K
LIN icon
13
Linde
LIN
$236B
$3.69M 3.21%
+23,649
New +$3.74M
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$4.12T
$3.58M 3.11%
68,500
-5,480
-7% -$296K
PEP icon
15
PepsiCo
PEP
$196B
$3.47M 3.01%
31,371
-481
-2% -$54.2K
CTSH icon
16
Cognizant
CTSH
$26.5B
$3.31M 2.88%
52,130
-528
-1% -$36.7K
WBA
17
DELISTED
Walgreens Boots Alliance
WBA
$3.13M 2.72%
45,851
-561
-1% -$43.5K
META icon
18
Meta Platforms (Facebook)
META
$1.49T
$3.05M 2.65%
23,268
-142
-0.6% -$20.6K
RTX icon
19
RTX Corp
RTX
$290B
$3.04M 2.64%
45,380
-286
-0.6% -$22.4K
TMO icon
20
Thermo Fisher Scientific
TMO
$214B
$2.89M 2.51%
12,920
-540
-4% -$127K
CCK icon
21
Crown Holdings
CCK
$13B
$2.55M 2.22%
61,428
-274
-0.4% -$12.7K
BKNG icon
22
Booking.com
BKNG
$156B
$2.41M 2.1%
35,000
-325
-0.9% -$23.8K
MNST icon
23
Monster Beverage
MNST
$95.1B
$2.18M 1.89%
88,554
-238
-0.3% -$6.46K
PYPL icon
24
PayPal
PYPL
$50.3B
$1.93M 1.68%
+22,952
New +$1.91M
GILD icon
25
Gilead Sciences
GILD
$165B
$1.64M 1.42%
26,179
+58
+0.2% +$4.05K

Similar funds

Marshall & Sullivan's Q4 2018 Portfolio in Review

As of Q4 2018, Marshall & Sullivan held 48 positions worth $115M, down 16% from $138M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Marshall & Sullivan withdrew a net $5.45M in Q4 2018, closing 9 positions and reducing 26 holdings. Its most notable exit was Praxair Inc, an estimated $3.85M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Marshall & Sullivan opened a new position in Linde worth $3.69M.

  • Marshall & Sullivan's largest Q4 2018 buy was Linde: 23,649 shares worth $3.69M.
  • Marshall & Sullivan added most to Mastercard in Q4 2018, an estimated $1.02M increase.
  • Marshall & Sullivan's biggest Q4 2018 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $528K.
  • Marshall & Sullivan fully exited Praxair Inc in Q4 2018, selling an estimated $3.85M.
  • Marshall & Sullivan's ten largest holdings make up 49% of its $115M portfolio in Q4 2018.
  • Marshall & Sullivan opened 2 new positions and closed 9 in Q4 2018.
  • Marshall & Sullivan's portfolio value fell 16% quarter-over-quarter to $115M.

Based on Marshall & Sullivan's 13F filing for Q4 2018, filed 28 Jan 2019.